Submitted:
12 May 2023
Posted:
16 May 2023
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Synthesis and the characteristics of tris(aminomethyl)phosphines

3. [CuX(NN)PR3] complexes

3.1. X-ray structures of the complexes
3.2. Solid state luminescence
4. Antimicrobial activity
| Ref. | Compound | E. coli | P. aeruginosa | S. aureus | C. albicans |
|---|---|---|---|---|---|
| [8] | 1 | > 2560 | > 2560 | > 2560 | 640 |
| 2 | > 2560 | > 2560 | > 2560 | > 2560 | |
| 3 | 1280 | 1280 | 640 | 1280 | |
| [CuI(bpy)1] | 2560 | 2560 | 320 | 1280 | |
| [CuI(bpy)2] | 1280 | 2560 | 320 | 2560 | |
| [CuI(bpy)3] | 640 | 2560 | 320 | 2560 | |
| [CuI(phen)1] | 320 | 2560 | 80 | 160 | |
| [CuI(phen)2] | 320 | 1280 | 80 | 160 | |
| [CuI(phen)3] | 320 | 2560 | 80 | 160 | |
| [11] | [CuI(phen)1]·1 | 160 | 1280 | 40 | 160 |
| [CuI(phen)3]·3 | 160 | 2560 | 20 | 160 | |
| [CuI(phen)5]·5 | 160 | * | 20 | 40 | |
| [CuI(dmp)1] | 80 | * | 5.0 | 2.5 | |
| [CuI(dmp)1]·1 | 80 | 2560 | 2.5 | 2.5 | |
| [CuI(dmp)3] | 80 | * | 2.5 | 2.5 | |
| [CuI(dmp)3]·3 | 80 | 2560 | 2.5 | 2.5 | |
| [CuI(dmp)5]·5 | 80 | * | 2.5 | 1.25 | |
| [14] | [CuNCS(dmp)3] | 250 | * | 2 | 1 |
| [CuI(dmp)3S] | 200 | * | 2 | 1 | |
| [CuNCS(dmp)3S] | 250 | * | 2 | 2 | |
| ciprofloxacin | 0.1 | * | 0.5 | > 300 | |
| gentamycin | 10 | * | 5 | > 300 | |
| ampicillin | 1 | * | 0.2 | > 300 | |
| [15] | [CuI(bq)3] | > 300 | * | 20 | 100 |
5. In vitro cytotoxicity
6. Interactions with plasmid DNA and serum albumins

7. Conclusions
Funding
Acknowledgments
Conflicts of Interest
References
- Jin: S.; Guo, Y.; Guo, Z.; Wang, X. Monofunctional Platinum(II) Anticancer Agents. Pharmaceuticals 2021, 14, 133-. [CrossRef]
- Allardycea, C.S.; Dyson, P.J. Metal-based drugs that break the rules. Dalton Trans. 2016, 45, 3201-3209. [CrossRef]
- Anthony, E.J.; Bolitho, E.M.; Bridgewater, H.E.; Carter, O.W.L.; Donnelly, J.M.; Imberti, C.; Lant, E.C.; Lermyte, F.; Needham, R.J.; Palau, M.; Sadler, P.J.; Shi, H.; Wang, F.-X.; Zhang, W.-Y.; Zhang, Z. Metallodrugs are unique: opportunities and challenges of discovery and development. Chem. Sci. 2020, 11, 12888-12917. [CrossRef]
- Karges J.; Stokes, R.W.; Cohen, S.M. Metal Complexes for Therapeutic Applications. Trends Chem. 2021, 3, 523-534. [CrossRef]
- Franz, K.J.; Metzler-Nolte, N. Introduction: Metals in Medicine. Chem. Rev. 2019, 119, 727–772. [CrossRef]
- Ji, P.; Wang, P.; Chen, H.; Xu, Y.; Ge, J.; Tian, Z.; Yan, Z. Potential of Copper and Copper Compounds for Anticancer Applications. Pharmaceuticals 2023, 16, 234. [CrossRef]
- Santini, C.; Pellei, M.; Gandin, V.; Porchia, M.; Tisato, F.; Marzano, C. Advances in Copper Complexes as Anticancer Agents. Chem. Rev. 2014, 114, 1, 815–862. [CrossRef]
- Starosta, R.; Florek, M.; Król, J.; Puchalska, M.; Kochel, A. Copper(I) iodide complexes containing new aliphatic aminophosphine ligands and diimines - luminescent properties and antibacterial activity. New J. Chem. 2010, 34, 1441-1449. [CrossRef]
- Starosta, R.; Bażanów, B.; Barszczewski W. Chalcogenides of the aminomethylphosphines derived from 1-methylpiperazine, 1-ethylpiperazine and morpholine: NMR, DFT and structural studies for determination of electronic and steric properties of the phosphines. Dalton Trans. 2010, 39, 7547-7555. [CrossRef]
- Starosta, R.; Puchalska, M.; Cybińska, J.; Barys, M.; Mudring, A.-V. Structures, electronic properties and solid state luminescence of Cu(I) iodide complexes with 2,9-dimethyl-1,10-phenanthroline and aliphatic aminomethylphosphines or triphenylphosphine. Dalton Trans. 2011, 40, 2459-2468. [CrossRef]
- Starosta, R.; Stokowa, K.; Florek, M.; Król, J.; Chwiłkowska, A.; Kulbacka, J.; Saczko, J.; Skała, J.; Jeżowska-Bojczuk, M. Biological activity and structure dependent properties of cuprous iodide complexes with phenanthrolines and water soluble tris(aminomethyl)phosphanes. J. Inorg. Biochem. 2011, 105, 1102-1108. [CrossRef]
- Starosta, R.; Komarnicka, U.K.; Sobczyk, M.; Barys, M. Laser induced multi-component luminescence of [CuNCS(1,10-phen)P(CH2N(CH2CH2)2O)3]–the first example of CuNCS complexes with diimines and tris(aminomethyl)phosphanes. J. Lumin. 2012, 132, 1842-1847. [CrossRef]
- Starosta, R.; Komarnicka, U.K.; Puchalska, M.; Barys, M. Solid state luminescence of copper(I) (pseudo)halide complexes with neocuproine and aminomethylphosphanes derived from morpholine and thiomorpholine. New J. Chem. 2012, 36, 1673-1683. [CrossRef]
- Starosta, R.; Bykowska, A.; Kyzioł, A.; Płotek, M.; Florek, M.; Król, J.; Jezowska-Bojczuk, M. Copper(I) (pseudo)halide complexes with neocuproine and aminomethylphosphines derived from morpholine and thiomorpholine - in vitro cytotoxic and antimicrobial activity and the interactions with DNA and Serum Albumins. Chem. Biol. Drug Des. 2013, 82, 579-586. [CrossRef]
- Starosta, R.; Brzuszkiewicz, A.; Bykowska, A.; Komarnicka, U.K.; Bażanów, B.; Florek, M.; Gadzała, Ł.; Jackulak, N.; Król, J.; Marycz, K. A novel copper(I) complex, [CuI(2,2'-biquinoline)P(CH2N(CH2CH2)2O)3] – synthesis, characterisation and comparative studies on biological activity. Polyhedron 2013, 50, 481-489. [CrossRef]
- Starosta, R.; Komarnicka, U.K.; Puchalska, M. Luminescent copper(I) (pseudo)halide complexes with neocuproine and a novel bulky tris(aminomethyl)phosphine derived from 2-piperazinopyridine. J. Lumin. 2013, 143, 137-144. [CrossRef]
- Starosta, R.; Komarnicka, U.K.; Puchalska, M. Solid state luminescence of CuI and CuNCS complexes with phenanthrolines and a new tris(aminomethyl)phosphine derived from N-methyl-2-phenylethanamine. J. Lumin. 2014, 145, 430-437. [CrossRef]
- Coates, H.; Hoye P.A.T. Br. Pat., 842 593, 1960.; Coates, H.; Hoye P. A. T. US Pat., 3 035 053, 1962.
- Moiseev, D.V.; James B.R. Phospha-Mannich reactions of PH3 and its analogs. Phosphorus, Sulfur, and Silicon and the Related Elements 2022, 197, 277-326. [CrossRef]
- Smith, M.B. The Backbone of Success of P,N-Hybrid Ligands: Some Recent Developments. Molecules 2022, 27, 6293. [CrossRef]
- Keen, A.L.; Doster, M.; Han, H.; Johnson, S.A. Facile assembly of a Cu9 amido complex: a new tripodal ligand design that promotes transition metal cluster formation. Chem. Commun. 2006, 1221–1223. [CrossRef]
- Hatnean, J.A.; Raturi, R.; Lefebvre, J.; Leznoff, D.B.; Lawes, G.; Johnson S.A. Assembly of Triangular Trimetallic Complexes by Triamidophosphine Ligands: Spin-Frustrated Mn2+ Plaquettes and Diamagnetic Mg2+ Analogues with a Combined Through-Space, Through-Bond Pathway for 31P-31P Spin−Spin Coupling. J. Am. Chem. Soc. 2006, 128, 14992–14999. [CrossRef]
- Han, H.; Elsmaili, M.; Johnson, S.A. Diligating Tripodal Amido-Phosphine Ligands: the Effect of a Proximal Antipodal Early Transition Metal on Phosphine Donor Ability in a Building Block for Heterometallic Complexes. Inorg. Chem. 2006, 45, 7435-7445. [CrossRef]
- Marzano, C.; Gandin, V.; Pellei, M.; Colavito, D.; Papini, G.; Lobbia, G.G.; Del Giudice, E.; Porchia, M.; Tisato, F.; Santini, C. In Vitro Antitumor Activity of the Water Soluble Copper(I) Complexes Bearing the Tris(hydroxymethyl)phosphine Ligand. J. Med. Chem. 2008, 51, 798-808. [CrossRef]
- Marzano, C.; Pellei, M.; Alidori, S.; Brossa, A.; Lobbia, G.G.; Tisato, F.; Santini, C. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity. J. Inorg. Biochem. 2006, 100, 299-304. [CrossRef]
- Rauf, M.K.; Imtiaz-ud-Din; Badshah, A.; Gielen, M.; Ebihara, M.; de Vos, D.; Ahmed, S. Synthesis, structural characterization and in vitro cytotoxicity and anti-bacterial activity of some copper(I) complexes with N,N'-disubstituted thioureas. J. Inorg. Biochem. 2009, 103, 1135-1140. [CrossRef]
- Sanghamitra, N.J.; Phatak, P.; Das, S.; Samuelson, A.G.; Somasusundaram, K. Mechanism of cytotoxicity of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane. J. Med. Chem., 2005, 48, 977-985. [CrossRef]
- McKeage, M.J.; Papathanasiou, P.; Salem, G.; Sjaarda, A.; Swiegers, G.F.; Waring, P.; Wild, S.B. Antitumor activity of gold(i), silver(i) and copper(i) complexes containing chiral tertiary phosphines. Metal-Based Drugs 1998, 5, 217-223. [CrossRef]
- Balakrishna, M.S.; Suresh, D.; Rai, A.; Mague, J.T.; Panda, D. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells. Inorg. Chem. 2010, 49, 8790-87801. [CrossRef]
- Lazarou, K.; Bednarz, B.; Kubicki, M.; Verginadis, I.I.; Charalabopoulos, K.; Kourkoumelis, N.; Hadjikakou, S.K. Structural photolysis and biological studies of the bis(μ2-chloro)-tris(triphenylphosphine)-di-copper(I) and chloro-tris(triphenylphosphine)-copper(I) complexes. Study of copper(I)-copper(I) interactions. Inorg. Chim. Acta 2010, 363, 763-772. [CrossRef]
- Marzano, C.; Pellei, M.; Colavito, D.; Alidori, S.; Lobbia, G.G.; Gandin, V.; Tisato, F.; Santini, C. Synthesis, Characterization, and in Vitro Antitumor Properties of Tris(hydroxymethyl)phosphine Copper(I) Complexes Containing the New Bis(1,2,4-triazol-1-yl)acetate Ligand. J. Med. Chem. 2006, 49, 7317-7324. [CrossRef]
- Marzano, C.; Pellei, M.; Tisato, F.; Santini, C. Copper complexes as anticancer agents. Anti-Cancer Agents in Med. Chem. 2009, 9, 185-211. [CrossRef]
- Vorontsov, I.I.; Graber, T.; Kovalevsky, A.Y.; Novozhilova, I.V.; Gembicky, M.; Chen, Y.-S.; Coppens, P. Capturing and Analyzing the Excited-State Structure of a Cu(I) Phenanthroline Complex by Time-Resolved Diffraction and Theoretical Calculations. J. Am. Chem. Soc. 2009, 131, 6566-6573. [CrossRef]
- Kirchhoff, J.R.; McMillin, D.R.; Robinson, W.R.; Powell, D.R.; McKenzie, A.T.; Chen, S. Steric effects and the behavior of Cu(NN)(PPh3)2+ systems in fluid solution. Crystal and molecular structures of [Cu(dmp)(PPh3)2]NO3 and [Cu(phen)(PPh3)2]NO3∙1.5EtOH. Inorg Chem. 1985, 24, 3928-393. [CrossRef]
- Sakaki, S.; Mizutani, H.; Kase, Y.; Inokuchi, K.; Arai, T.; Hamada, T. Photoinduced electron transfer between [Cu(dmphen)L2]+ [dmphen = 2,9-dimethyl-1,10-phenanthroline, L = PPhn(C6H4OMe-p)3–n (n= 0–3)] and methyl viologen. J. Chem. Soc., Dalton Trans. 1996, 1909-1914. [CrossRef]
- Sun, Y.; Zhang, S.; Li, G.; Xie, Y.; Zhao, D. Crystallographic and spectroscopic studies of a luminescent binuclear copper(I) complex containing mixed-ligands. Trans. Met. Chem. 2003, 28, 772-776. [CrossRef]
- Li, D.; Li, R.-Z.; Ni, Z.; Qi, Z-Y.; Feng, X.-L.; Cai, J.-W. Synthesis and crystal structure of photoluminescent copper(I)–phosphine complexes with oxygen and nitrogen donor ligands. Inorg. Chem. Commun. 2003, 6, 469-473. [CrossRef]
- Yang, L.; Feng, J.-K.; Ren, A.-M.; Zhang, M.; Ma, Y.-G.; Liu, X.-D. Structures, Electronic States and Electroluminescent Properties of a Series of CuI Complexes. Eur. J. Inorg. Chem. 2005, 1867-1879. [CrossRef]
- McCormic, T.; Jia, W.-L.; Wang, S. Phosphorescent Cu(I) Complexes of 2-(2‘-pyridylbenzimidazolyl)benzene: Impact of Phosphine Ancillary Ligands on Electronic and Photophysical Properties of the Cu(I) Complexes. Inorg. Chem. 2006, 45, 147-155. [CrossRef]
- Moudam, O.; Kaeser, A.; Dalavoux-Nicot, B.; Duhayon, C.; Holler, M.; Accorsi, G.; Séguy, I.; Destruel P.; Nierengarten, J.-F. Electrophosphorescent homo- and heteroleptic copper(i) complexes prepared from various bis-phosphine ligands. Chem. Commun. 2007, 3077-3079. [CrossRef]
- Fu, W.F.; Gan, X.; Jiao, J.; Chen, Y.; Yuan, M.; Chi, S.-M.; Yu, M.-M.; Xiong, S.-X. Synthesis, structural and spectroscopic characterization of mono- and binuclear copper(I) complexes with substituted diimine and phosphine ligands. Inorg. Chim. Acta 2007, 360, 2758-2766. [CrossRef]
- Listorti, A.; Accorsi, G.; Rio, Y.; Armaroli, N.; Moudam, O.; Gégout, A.; Delavaux-Nicot, B.; Holler, M.; Nierengarten, J.F. Heteroleptic Copper(I) Complexes Coupled with Methano[60]fullerene: Synthesis, Electrochemistry, and Photophysics. Inorg Chem. 2008, 47, 6254-6262. [CrossRef]
- Zhang, L.; Li, B.; Su, Z. Realization of High-Energy Emission from [Cu(N−N)(P−P)]+ Complexes for Organic Light-Emitting Diode Applications. J. Phys. Chem. C. 2009, 113, 13968-13973. [CrossRef]
- Zhang, L.; Li, B.; Su, Z. Phosphorescence Enhancement Triggered by Π Stacking in Solid-State [Cu(N−N)(P−P)]BF4 Complexes. Langmuir 2009, 25, 2068-2074. [CrossRef]
- Shi, Y.-J.; Chen, S.-J.; Huang, B.; Chen, X.-T.; Zhang, Y.; You, X.-Z. The preparation, crystal structure and properties of a mixed-ligand copper(I) complex [CuI(PPh3)(DPPZ)]·DMF. J. Mol. Struct. 2003, 650, 27-32. [CrossRef]
- Gan, X.; Fu, W.-F.; Lin, Y.-Y.; Yuan, M.; Che, C.-M.; Chi, S.-M.; Li, H.-F.J.; Chen, J.-H.; Zhou, Z.-Y. Synthesis, structures and photophysical properties of polynuclear copper(I) iodide complexes containing phosphine and 4,4′-bipyridine ligands. Polyhedron 2008, 27, 2202-2208. [CrossRef]
- Pettinari, C.; di Nicola, C.; Marchetti, F.; Pettinari, R.; Skelton, B.W.; Somers, N.; White, A.H.; Robinson, W.T.; Chierotti, M.R.; Gobetto, R.; Nervi, C. Synthesis, characterization, spectroscopic and photophysical properties of new [Cu(NCS){(L-N)2 or (L′-N∧N)}(PPh3)] complexes (L-N, L′-N∧N = aromatic nitrogen base). Eur. J. Inorg. Chem. 2008, 1974-1984. [CrossRef]
- Krauter, J.G.E.; Beller, M. An Easy and Practical Synthetic Route to Electron Rich Water Soluble Ligands: α-Aminomethylation of Trishydroxymethylphosphine. Tetrahedron 2000, 56, 771-774. [CrossRef]
- Tolman, C.A. Electron donor-acceptor properties of phosphorus ligands. Substituent additivity. J. Am. Chem. Soc., 1970, 92, 2953-2956. [CrossRef]
- Dunne, B.J.; Morris, R.B.; Orpen, A.G.J. Structural systematics. Part 3. Geometry deformations in triphenylphosphine fragments: a test of bonding theories in phosphine complexes. J. Chem. Soc., Dalton Trans. 1991, 653-661. [CrossRef]
- Suresh, C.H.; Molecular electrostatic potential approach to determining the steric effect of phosphine ligands in organometallic chemistry. Inorg. Chem. 2006, 45, 4982-4986. [CrossRef]
- Dunne, B.J.; Orpen, A.G. Triphenylphosphine: a redetermination. Acta Cryst. 1991, C47, 345-347. [CrossRef]
- Suresh, C.H.; Koga, N. Quantifying the Electronic Effect of Substituted Phosphine Ligands via Molecular Electrostatic Potential. Inorg. Chem. 2002, 41, 1573-1578. [CrossRef]
- Mathew, J.; Thomas, T.; Suresh, C.H.; Quantitative Assessment of the Stereoelectronic Profile of Phosphine Ligands. Inorg. Chem. 2007, 46, 10800-10809. [CrossRef]
- Shannon, R.D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Cryst. 1976, A32, 751–767. [CrossRef]
- Tsuboyama, A.; Kuge, K.; Furugori, M.; Okada, S.; Hoshino, M.; Ueno, K. Photophysical properties of highly luminescent copper(I) halide complexes chelated with 1,2-bis(diphenylphosphino)benzene. Inorg Chem. 2007, 46, 1992-2001. [CrossRef]
- Chen, J.-L.; Song, P.; Liao, J.; Wen, H.-R.; Hong, R.; Chen, Z.-N.; Chi, Y. Luminescent homodinuclear copper(I) halide complexes based on the 3,5-bis{6-(2,2′-dipyridyl)}pyrazole ligand. Inorg. Chem. Commun. 2010, 13, 1057-1060. [CrossRef]
- Du, L.; Lan, Z. Ultrafast structural flattening motion in photoinduced excited state dynamics of a bis(diimine) copper(i) complex. Phys. Chem. Chem. Phys. 2016, 18, 7641-7650. [CrossRef]
- Viganor, L.; Howe, O.; McCarron, P.; McCann, M.; Devereux, M.; The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance, Curr. Topics Med. Chem. 2017, 17, 1280 - 1302. [CrossRef]
- Zwicker, F.; Hauswald, H.; Debus, J.; Huber, P.E.; Weber, K. J. Impact of dimethyl sulfoxide on irradiation-related DNA double-strand-break induction, -repair and cell survival. Radiat. Eenviron. Biophys. 2019, 58, 417–424. [CrossRef]
- Petitpas, I.; Bhattacharya, A.A.; Twine, S.; East, M.; Curry, S. Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin: Anatomy of Drug Site I. J. Biol. Chem. 2001, 276, 22804-22809. [CrossRef]
- Phosphine: Lung Damaging Agent https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750035.html accessed on 26.04.2023.
- Phosphine. Toxicological review. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/338253/HPA_Phosphine_toxicological_overview_v1.pdf accessed on 26.04.2023.
- Ganesan, K.; Raza, S.K.; Vijayaraghavan, R. Chemical warfare agents. J. Pharm. Bioallied. Sci. 2010, 2, 166–178. [CrossRef]
- M.C. Rosko, E.M. Espinoza, S. Arteta, S. Kromer, J.P. Wheeler, F.N. Castellano Employing Long-Range Inductive Effects to Modulate Metal-to-Ligand Charge Transfer Photoluminescence in Homoleptic Cu(I) Complexes. Inorg. Chem. 2023, 62, 3248-3259. [CrossRef]
- Mei, J.; Leung, N.L.C.; Kwok, R.T.K.; Lam, J.W.Y.; Tang, B.Z. Aggregation-Induced Emission: Together We Shine, United We Soar Chem. Rev. 2015, 115, 11718–11940. [CrossRef]
- Zhu, C.; Kwok, R.T.K.; Lam, J.W.Y.; Tang, B.Z. Aggregation-Induced Emission: A Trailblazing Journey to the Field of Biomedicine. ACS Appl. Bio Mater. 2018, 1, 1768–1786. [CrossRef]
- Duo, Y.; Luo, G.; Zhang, W.; Wang, R.; Xiao, G.G.; Li, Z.; Li, X.; Chen, M.; Yoon, J.; Tang, B.Z. Noncancerous disease-targeting AIEgens. Chem. Soc. Rev. 2023, 52, 1024-1067. [CrossRef]
- Kaim, W.; Schwederski, B. Non-innocent ligands in bioinorganic chemistry — An overview. Coord. Chem. Rev. 2010, 254, 1580-1588. [CrossRef]




| 1 | 2 | 3 | 3S | 5 | 6 | 7 | PPh3 | |
|---|---|---|---|---|---|---|---|---|
| XRD | ||||||||
| av.: d(P-C) [Å] | 1.855 | 1.856 | 1.845 | 1.830 [52] | ||||
| av.: α(C-P-C) [deg] | 97.89 | 97.91 | 98.8 | 102.7 [52] | ||||
| S4’ | 64.8 | 64.6 | 59.8 | 8.5 [52] | ||||
| DFT | ||||||||
| Θ [deg] | 210.2 | 218.9 | 206.7 | 213.5 | 194.8 | 194.7 | 207.7 | 145 |
| S4 | 63.7 | 63.7 | 63.4 | 63.5 | 63.4 | 63.2 | 64.2 | 40.2 |
| Vmin [kcal/mol] | -35.74 | -36.06 | -30.38 | -27.95 | -31.71 | -35.10 | -32.22 | -34.67 |
| Seff | 2.70 | 2.73 | 2.66 | 2.74 | 2.74 | 2.67 | 2.67 | 6.41 |
| Eeff | 4.92 | 5.21 | -0.40 | -2.91 | 0.85 | 4.51 | 1.43 | 0.15 |
| Compound | Ref. | NMR | X-ray | DFT | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| δ(P) | δ(C1) | 1J(PC1) | δ(H1) | 2J(PH1) | S4’ | av. r(P-C) | S4 | av. r(P-C1) | ||
| 3 | [8,9] | -62.8 | 59.3 | 4.3 | 2.64 | 2.9 | 59.8 | 1.845(3) | 63.4 | 1.8820 |
| O=3 | [9] | 44.2 | 55.0 | 81.2 | 2.82 | 7.2 | 34.5 | 1.821(2) | 32.5 | 1.8532 |
| S=3 | [9] | 42.4 | 58.0 | 67.0 | 3.03 | 5.2 | 35.1 | 1.822(2) | 39.3 | 1.8694 |
| Se=3 | [9] | 26.3 | 57.8 | 59.8 | 3.18 | 4.6 | 31.4 | 1.825(3) | 39.9 | 1.8688 |
| 33.3 | 1.829(3) | |||||||||
| [CuI(bpy)3] | [8] | -35* | 55.8 | 26.0 | 2.88* | - | ||||
| [CuI(phen)3] | [8] | -35* | 56.4 | 24.4 | 2.87* | - | 50.7 | 1.837(6) | 49.6 | 1.8750 |
| [CuNCS(phen)3] | [12] | -32* | 55.5 | 25.9 | 2.76* | - | 53.7 | 1.843(1) | 48.8 | |
| [CuI(dmp)3]·3 | [10] | -29*; -60* | 56.6* | - | 2.77* | - | ||||
| [CuI(dmp)3] | [10,13] | -28* | 55.8* | - | 2.88* | - | 58.1 | 1.855(2) | 57.6 | 1.8844 |
| [CuNCS(dmp)3] | [13] | -30* | 56.5* | - | 2.74* | - | 62.0 | 1.853(2) | 56.5 | 1.8819 |
| [CuI(bq)3] | [15] | -28* | 55.2* | - | 2.78* | - | 44.0 | 1.844(3) | 54.1 | 1.8421 |
| Ref. | Compound | Cu1 - I1 | Cu1-N1 | Cu1-N1-C1 | Cu1 - P1 | av. (P1-C) | α | β - γ | S4’ |
|---|---|---|---|---|---|---|---|---|---|
| [8] | 3 | 1.845(3) | 59.8 | ||||||
| [8] | [CuI(phen)3] | 2.631(1) | 2.193(2) | 1.837(6) | 79.8 | 12.0 | 50.7 | ||
| [12] | [CuNCS(phen)3] | 1.989(1) | 164.81(9) | 2.1885(3) | 1.843(1) | 89.2 | 10.2 | 53.7 | |
| [10] | [CuI(dmp)3] | 2.674(1) | 2.206(1) | 1.855(2) | 85.6 | 33.3 | 58.1 | ||
| [13] | [CuNCS(dmp)3] | 1.969(1) | 175.27(12) | 2.197(1) | 1.853(2) | 89.2 | 20.2 | 62.0 | |
| [15] | [CuI(bq)3] | 2.609(2) | 2.216(2) | 1.844(3) | 80.1 | 13.8 | 44.7 |
| Ref. | Compound | SKOV 3 | MDAH 2774 |
|---|---|---|---|
| [11] | [CuI(phen)1]·1 | 3.2±0.3 | 7.0±0.7 |
| [CuI(phen)3]·3 | 1.9±0.1 | 6.5±0.2 | |
| [CuI(phen)5]·5 | 2.2±0.3 | 4.2±0.2 | |
| [CuI(dmp)1]·1 | 1.8±0.1 | 2.0±0.5 | |
| [CuI(dmp)3]·3 | 2.2±0.1 | 3.0±0.1 | |
| [CuI(dmp)5]·5 | 2.0±0.4 | 4.0±0.4 | |
| cisplatin | 180.5±9.3 | 77.2±7.6 |
| 4 h | 24 h | 48 h | |||||
|---|---|---|---|---|---|---|---|
| Ref. | Compound | CT26 | A549 | CT26 | A549 | CT26 | A549 |
| [14] | [CuI(dmp)3] | 9.06 ± 0.48 | 1.56 ± 0.39 | 14650±340 | 280±60 | 193.53±11.31 | 35.03±6.26 |
| [CuNCS(dmp)3] | 6.78 ± 0.47 | 4.99 ± 0.40 | 1200±560 | 80 ± 10 | 65.38±5.68 | 21.23±2.82 | |
| [CuI(dmp)3S] | 5.37 ± 0.65 | 4.04 ± 0.38 | 2330±430 | 180 ± 80 | 86.49±4.95 | 27.87±4.24 | |
| [CuNCS(dmp)3S] | 2.12 ± 0.29 | 6.10 ± 0.73 | 5750±320 | 140 ± 30 | 611.31±17.67 | 45.28±4.64 | |
| cisplatin | 2200 ± 820 | 3150 ± 450 | 4990 ± 670 | 3850 ± 430 | 39040 ± 5450 | 43310 ± 7210 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).